New formulation of vasoactive intestinal peptide using liposomes in hyaluronic acid gel for uveitis

Journal of Controlled Release

Volumn 139, Issue 1, 2009, Pages 22-30

  Lajavardi, Laure ^a,b,c,d   Camelo, Serge ^b,c,d   Agnely, Florence ^a   Luo, Wei ^a   Goldenberg, Brigitte ^b,c,d   Naud, Marie Christine ^b,c,d   Behar Cohen, Francine ^b,c,d   de Kozak, Yvonne ^b,c,d   Bochot, Amélie ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b INSERM   (France)

^c CENTRE DE RECHERCHE DES CORDELIERS   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Biodistribution; Hyaluronic acid gel; Intraocular administration; Liposomes; Rheological studies; Uveitis; Vasoactive intestinal peptide

Indexed keywords

BIODISTRIBUTION; HYALURONIC ACID GEL; INTRAOCULAR ADMINISTRATION; RHEOLOGICAL STUDIES; UVEITIS; VASOACTIVE INTESTINAL PEPTIDE;

AMINES; BODY FLUIDS; DRUG THERAPY; FLUORESCENCE MICROSCOPY; GELATION; HYDROXYLATION; LIPOSOMES; ORGANIC ACIDS; PATHOLOGY; PEPTIDES; PHOSPHOLIPIDS; POLYSACCHARIDES; RHEOLOGY; RHODIUM; SUSTAINABLE DEVELOPMENT; SYSTEM STABILITY; TISSUE;

GELS;

ENDOTOXIN; HYALURONIC ACID; LIPOPOLYSACCHARIDE; LIPOSOME; RHODAMINE; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; CONJUGATION; CONTROLLED STUDY; DISEASE SEVERITY; ELASTICITY; EYE INFLAMMATION; FLOW KINETICS; FLUORESCENCE MICROSCOPY; GEL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY CELL; INGUINAL LYMPH NODE; LIPOSOMAL DELIVERY; MALE; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RAT; SCORING SYSTEM; SPLEEN; UVEITIS; VISCOSITY;

ALGORITHMS; ANIMALS; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; ELASTICITY; ENDOTOXINS; FLUORESCEINS; GELS; HYALURONIC ACID; INJECTIONS; LIPOSOMES; MALE; PARTICLE SIZE; RATS; RATS, INBRED LEW; RHEOLOGY; UVEITIS; VASOACTIVE INTESTINAL PEPTIDE; VISCOSITY; VITREOUS BODY;

EID: 69249222639     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2009.05.033     Document Type: Article

References (41)

1. Caspi R.R. Immunotherapy of uveitis: is gene therapy in our future?. In: Krieglstein G.K., and Weinreb R.N. (Eds). Essentials in Ophthalmology. Uveitis and Immunological Disorders (2007), Springer, New York 193-210
2. Foster C.S., and Vitale A.T. Diagnosis and Treatment of Uveitis. 1 ed (2002), W.B. Saunders, Philadelphia
3. Jaffe G.J., Martin D., Callanan D., Pearson P.A., and Levy Band Comstock T. Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study. Ophthalmology 113 (2006) 1020-1027
4. Mohammad D.A., Sweet B.V., and Elner S.G. Retisert: is the new advance in treatment of uveitis a good one?. Ann. Pharmacother. 41 (2007) 449-454
5. Valamanesh F., Torriglia A., Savoldelli M., Gandolphe C., Jeanny J.C., BenEzra D., and Behar-Cohen F. Glucocorticoids induce retinal toxicity through mechanisms mainly associated with paraptosis. Mol. Vis. 13 (2007) 1746-1757
6. Camelo S., Lajavardi L., Bochot A., Goldenberg B., Naud M.C., Brunel N., Lescure B., Klein C., Fattal E., Behar-Cohen F., and De Kozak Y. Protective effect of intravitreal injection of vasoactive intestinal peptide (VIP)-loaded liposomes on experimental autoimmune uveoretinitis. J. Ocular Pharmacol. Ther. 25 (2009) 9-21
7. Lajavardi L., Bochot A., Camelo S., Goldenberg B., Naud M.C., Behar-Cohen F., Fattal E., and de Kozak Y. Downregulation of endotoxin-induced uveitis by intravitreal injection of vasoactive intestinal peptide encapsulated in liposomes. Invest. Ophthalmol. Vis. Sci. 48 (2007) 3230-3238
8. Camelo S., Lajavardi L., Bochot A., Goldenberg B., Naud M.C., Fattal E., Behar-Cohen F., and de Kozak Y. Drainage of fluorescent liposomes from the vitreous to cervical lymph nodes via conjunctival lymphatics. Ophthalmic Res. 40 (2008) 145-150
9. Van Kooij B., Rothova A., and de Vries P. The pros and cons of intravitreal triamcinolone injections for uveitis and inflammatory cystoid macular edema. Ocul. Immunol. Inflamm. 14 (2006) 73-85
10. Bochot A., Fattal E., Gulik A., Couarraze G., and Couvreur P. Liposomes dispersed within a thermosensitive gel: a new dosage form for ocular delivery of oligonucleotides. Pharm. Res. 15 (1998) 1364-1369
11. Boulmedarat L., Piel G., Bochot A., Lesieur S., Delattre L., and Fattal E. Cyclodextrin-mediated drug release from liposomes dispersed within a bioadhesive gel. Pharm. Res. 22 (2005) 962-971
12. Mourtas S., Fotopoulou S., Duraj S., Sfika V., Tsakiroglou C., and Antimisiaris S.G. Liposomal drugs dispersed in hydrogels. Effect of liposome, drug and gel properties on drug release kinetics. Colloids Surf., B Biointerfaces 55 (2007) 212-221
13. Laurent T.C., and Fraser J.R. Hyaluronan. Faseb J. 6 (1992) 2397-2404
14. Bishop P. The biochemical structure of mammalian vitreous. Eye 10 Pt 6 (1996) 664-670
15. Crafoord S., and Stenkula S. Healon(R) GV in posterior segment surgery. Acta Ophthalmol. 71 (1993) 560-561
16. Moreira Jr. C.A., Armstrong D.K., Jelliffe R.W., Moreira A.T., Woodford C.C., Liggett P.E., and Trousdale M.D. Sodium hyaluronate as a carrier for intravitreal gentamicin. An experimental study. Acta Ophthalmol. (Copenh.) 69 (1991) 45-49
17. Termeer C., Sleeman J.P., and Simon J.C. Hyaluronan - magic glue for the regulation of the immune response?. Trends Immunol. 24 (2003) 112-114
18. Bangham A.D., Standish M.M., and Watkins J.C. Diffusion of univalent ions across the lamellae of swollen phospholipids. J. Mol. Biol. 13 (1965) 238-252
19. Séjourné F., Rubinstein I., Suzuki H., and Alkan-Onyuksel H. Development of a novel bioactive formulation of vasoactive intestinal peptide in sterically stabilized liposomes. Pharm. Res. 14 (1997) 362-365
20. Luk A.S., Kaler E.W., and Lee S.P. Structural mechanisms of bile salt-induced growth of small unilamellar cholesterol - lecithin vesicles. Biochemistry-Us 36 (1997) 5633-5644
21. Bartlett G.R. Phosphorus assay in column chromatography. J. Biol. Chem. 234 (1959) 466-468
22. de la Fuente M., Seijo B., and Alonso M.J. Novel hyaluronic acid-chitosan nanoparticles for ocular gene therapy. Invest. Ophthalmol. Vis. Sci. 49 (2008) 2016-2024
23. Gomez-Gaete C., Tsapis N., Silva L., Bourgaux C., Besnard M., Bochot A., and Fattal E. Supramolecular organization and release properties of phospholipid-hyaluronan microparticles encapsulating dexamethasone. Eur. J. Pharm. Biopharm. 70 (2008) 116-126
24. Evanko S.P., and Wight T.N. Intracellular localization of hyaluronan in proliferating cells. J. Histochem. Cytochem. 47 (1999) 1331-1342
25. Pouvreau I., Zech J.C., Thillaye-Goldenberg B., Naud M.C., Van Rooijen N., and de Kozak Y. Effect of macrophage depletion by liposomes containing dichloromethylene-diphosphonate on endotoxin-induced uveitis. J. Neuroimmunol. 86 (1998) 171-181
26. Camelo S., Lajavardi L., Bochot A., Goldenberg B., Naud M.C., Fattal E., Behar-Cohen F., and de Kozak Y. Ocular and systemic bio-distribution of rhodamine-conjugated liposomes loaded with VIP injected into the vitreous of Lewis rats. Mol. Vis. 13 (2007) 2263-2274
27. Mantovani A., Sozzani S., Locati M., Allavena P., and Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23 (2002) 549-555
28. Lym H.S., Suh Y., and Park C.K. Effects of hyaluronic acid on the polymorphonuclear leukocyte (PMN) release of active oxygen and protection of bovine corneal endothelial cells from activated PMNs. Korean J. Ophthalmol. 18 (2004) 23-28
29. Day A.J., and de la Motte C.A. Hyaluronan cross-linking: a protective mechanism in inflammation?. Trends Immunol. 26 (2005) 637-643
30. Boulmedarat L., Grossiord J.L., Fattal E., and Bochot A. Influence of methyl-beta-cyclodextrin and liposomes on rheological properties of Carbopol 974P NF gels. Int. J. Pharm. 254 (2003) 59-64
31. Mourtas S., Haikou M., Theodoropoulou M., Tsakiroglou C., and Antimisiaris S.G. The effect of added liposomes on the rheological properties of a hydrogel: a systematic study. J. Colloid Interface Sci. 317 (2008) 611-619
32. Crescenzi V., Taglienti A., and Pasquali-Ronchetti I. Supramolecular structures prevailing in aqueous hyaluronic acid and phospholipid vesicles mixtures: an electron microscopy and rheometric study. Colloids Surf., A 245 (2004) 133-135
33. Pasquali-Ronchetti I., Quaglino D., Mori G., Bacchelli B., and Ghosh P. Hyaluronan-phospholipid interactions. J. Struct. Biol. 120 (1997) 1-10
34. Brown D.J., Bishop P., Hamdi H., and Kenney M.C. Cleavage of structural components of mammalian vitreous by endogenous matrix metalloproteinase-2. Curr. Eye Res. 15 (1996) 435-445
35. Cuello C., Wakefield D., and Di Girolamo N. Neutrophil accumulation correlates with type IV collagenase/gelatinase activity in endotoxin induced uveitis. Br. J. Ophthalmol. 86 (2002) 290-295
36. Ruiz-Moreno J.M., Thillaye B., and de Kozak Y. Retino-choroidal changes in endotoxin-induced uveitis in the rat. Ophthalmic Res. 24 (1992) 162-168
37. Fraser J.R., and Laurent T.C. Turnover and metabolism of hyaluronan. Ciba Found Symp. 143 (1989) 41-53 discussion 53-49, 281-285
38. Hollyfield J.G., Rayborn M.E., Tammi M., and Tammi R. Hyaluronan in the interphotoreceptor matrix of the eye: species differences in content, distribution, ligand binding and degradation. Exp. Eye Res. 66 (1998) 241-248
39. Xu H., Chen M., Reid D.M., and Forrester J.V. LYVE-1-positive macrophages are present in normal murine eyes. Invest. Ophthalmol. Vis. Sci. 48 (2007) 2162-2171
40. Heindl L.M., Hofmann T.N., Knorr H.L., Rummelt C., Schrodl F., Schlotzer-Schrehardt U., Holbach L.M., Naumann G.O., Kruse F.E., and Cursiefen C. Intraocular lymphangiogenesis in malignant melanomas of the ciliary body with extraocular extension. Invest. Ophthalmol. Vis. Sci. 50 (2009) 1988-1995
41. Camelo S., Shanley A., Voon A.S., and McMenamin P.G. The distribution of antigen in lymphoid tissues following its injection into the anterior chamber of the rat eye. J. Immunol. 172 (2004) 5388-5395